The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex

European Journal of Heart Failure

Volumn 12, Issue 6, 2010, Pages 574-580

  Frankenstein, Lutz ^a   Remppis, Andrew ^a   Fluegel, Andrea ^b   Doesch, Andreas ^a   Katus, Hugo A ^a   Senges, Jochen ^c   Zugck, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^c Institut fur Herzinfarktforschung   (Germany)

Author keywords

Adherence to guidelines; Age; Chronic heart failure; Pharmacotherapy; Prognosis; Sex

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; COMORBIDITY; DISEASE REGISTRY; FEMALE; HEALTH CARE PLANNING; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGE FACTORS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; MORTALITY; REGISTRIES; SEX FACTORS;

EID: 77952992960     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq047     Document Type: Article

References (23)

1. Remme WJ, McMurray JJ, Rauch B, Zannad F, Keukelaar K, Cohen-Solal A, Lopez-Sendon J, Hobbs FD, Grobbee DE, Boccanelli A, Cline C, Macarie C, Dietz R, Ruzyllo W. Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J 2005;26:2413-2421.
2. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J IMPROVEMENT of Heart Failure Programme Committees, Investigators. Improvement programme in evaluation and management; Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360:1631-1639.
3. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme\a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464-674.
4. Opasich C, De Feo S, Ambrosio GA, Bellis P, Di Lenarda A, Di Tano G, Fico D, Gonzini L, Lavecchia R, Tomasi C, Maggioni AP TEMISTOCLE Investigators. The 'real' woman with heart failure. Impact of gender on current in-hospital management of heart failure by cardiologists and internists. Eur J Heart Fail 2004;6:769-779.
5. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, Tavazzi L, Poole-Wilson P, Le Pen C. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005;26:1653-1659.
6. Peters-Klimm F, Mueller-Tasch T, Schellberg D, Remppis A, Barth A, Holzapfel N, Jünger J, Herzog W, Szecsenyi J. Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol 2008;97:244-252.
7. Remme WJ, McMurray JJ, Hobbs FD, Cohen-Solal A, Lopez-Sendon J, Boccanelli A, Zannad F, Rauch B, Keukelaar K, Macarie C, Ruzyllo W, Cline C SHAPE Study Group. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J 2008;29:1739-1752.
8. de Groote P, Isnard R, Clerson P, Jondeau G, Galinier M, Assyag P, Demil N, Ducardonnet A, Thebaut JF, Komajda M. Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: The Impact-Reco Programme. Eur J Heart Fail 2009;11:85-91.
9. Peters-Klimm F, Mueller-Tasch T, Remppis A, Szecsenyi J, Schellberg D. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice\results from a cluster-randomized controlled trial of implementation of a clinical practice guideline. J Eval Clin Pract 2008;14:823-829.
10. Mejhert M, Holmgren J, Wandell P, Persson H, Edner M. Diagnostic tests, treatment and follow-up in heart failure patients\is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1999;1:407-410.
11. Harjai KJ, Nunez E, Stewart Humphrey J, Turgut T, Shah M, Newman J. Does gender bias exist in the medical management of heart failure? Int J Cardiol 2000;75:65-69.
12. Baumhaekel M, Mueller U, Boehm M. Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 2009;11:631-632.
13. de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M, Jondeau G, Leurs I, Thébaut JF, Komajda M. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail 2007;9:1205-1211.
14. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002;162:1682-1688.
15. Anderson GD. Gender and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 2005;14:19-29.
16. Störk S, Hense HW, Zentgraf C, Uebelacker I, Jahns R, Ertl G, Angermann CE. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure. A prospective cohort study. Eur J Heart Fail 2008;10:1236-1245.
17. Hoppe UC, Erdmann E. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie. Z Kardiol 1998;87: 645-658.
18. Hoppe UC, Erdmann E. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie. Z Kardiol 2001;90:218-237.
19. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pierard L, Remme WJ;, Task Force for the Diagnosis, Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140.
20. Hoppe UC, Boehm M, Dietz R, Hanrath P, Kroemer HK, Osterspey A, Schmaltz AA, Erdmann E;. Vorstand der Deutschen Gesellschaft fur Kardiolo-gie-Herz-und Kreislaufforschung e.V. [Guidelines for therapy of chronic heart failure]. Z Kardiol 2005;94:488-509.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine. A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
22. Hess G, Moecks J, Zdunek D. N-terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders. Z Kardiol 2005;94:247-254.
23. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-350.